The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
March 6th 2025
This February 2025 month in review covers key updates in endocrinology, including the end to the semaglutide shortage and new automated insulin delivery data.
February 21st 2025
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Insulin Pumps Show Benefits Beyond Convenience
Patients diagnosed with type 1 diabetes have long known the benefits of ease and convenience that comes with using an insulin pump instead of relying on multiple daily insulin injections to control their condition. A recent study has shown that using a pump is also associated with positive effects on long-term cardiovascular risk and mortality.
Delving Into Adherence With Multiple Sclerosis Therapies
September 16th 2014Adherence is defined as conforming to the recommendations made by the provider with respect to timing, dosage, and frequency of medication taking, and following these recommendations is important for patients with multiple sclerosis (MS) to fully benefit from disease-modifying therapies (DMTs).
Review Finds Little Evidence to Link Testosterone Therapy and Increased Cardiovascular Risk
Staff scientists at the US Food and Drug Administration (FDA) have concluded that there's no "convincing evidence" linking testosterone replacement therapy with adverse cardiovascular events.
Exposure to Endocrine-disrupting Chemicals Associated with Low Serum Testosterone
A new study showing significant negative correlation between phthalate absorption and testosterone levels adds considerably more weight and significant new details to a growing body of research.
Model Helps Predict Patient Risk for Major Type 1 Diabetes Complications
Patients diagnosed with type 1 diabetes are at higher risk for developing major health complications but up until now there had been no reliable way to determine which complications a patient might develop or how severe they might be.
Stage 2 Deadline Rapidly Approaching
The end of September will mark the deadline set for hospitals across the country to reach Stage 2 of the Meaningful Use program for the year and that means the clock is ticking for health care professionals around the country to meet the goals set for them.
VBLOCK Shows Success with Diabetes, Hypertension and Weight Loss
A 3-year study of a product meant to help patients dealing with a wide range of conditions including diabetes, hypertension, and weight loss showed positive results according to manufacturer EnteroMedics, Inc.
Poor Understanding of Gastroparesis Detrimental to Patients
Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.